/301130.SZ
301130.SZ Stock - Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
Basic Materials|ChemicalsSHZ
$29.22+0.55%
+$0.16 (+0.55%) • Dec 26
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $32.14
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 301130.SZ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$28.93 – $29.51
TARGET (TP)$33.60
STOP LOSS$26.88
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.63
52W High$36.98
52W Low$22.83
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $256.41M | $225.49M | $255.47M | $285.66M | $286.32M |
| Gross Profit | $196.21M | $180.99M | $208.54M | $238.95M | $242.41M |
| Gross Margin | 76.5% | 80.3% | 81.6% | 83.7% | 84.7% |
| Operating Income | $46.33M | $55.65M | $52.13M | $59.67M | $59.24M |
| Net Income | $40.27M | $50.50M | $40.72M | $52.02M | $49.74M |
| Net Margin | 15.7% | 22.4% | 15.9% | 18.2% | 17.4% |
| EPS | $0.52 | $0.62 | $0.50 | $0.64 | $0.62 |
Company Overview
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sale of pharmaceutical products. The company offers drugs for the treatment of anemia, mental disorders, cardiovascular diseases, tumors, etc., as well as traditional Chinese medicines and raw materials. It provides drugs in the form of oral solids and freeze-dried powder injections. The company was founded in 1993 and is based in Panshi, China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
301130.SZBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.22
Q2 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q2 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 30, 2025 | — | $0.22 | — | — |
Q2 2025 | May 23, 2025 | — | $0.08 | — | — |
Q1 2025 | Mar 31, 2025 | — | $0.11 | — | — |
Q3 2024 | Sep 29, 2024 | — | $0.13 | — | — |
Q2 2024 | Jun 29, 2024 | — | $0.14 | — | — |
Q2 2024 | May 24, 2024 | — | $0.17 | — | — |
Q1 2024 | Feb 23, 2024 | — | $0.14 | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.11 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.26 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.12 | — | — |
Q1 2023 | Jan 1, 2023 | — | $0.11 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.14 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.16 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.12 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.22 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.14 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.21 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.17 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.20 | — | — |
Q3 2020 | Sep 30, 2020 | — | $0.20 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 301130.SZ
What is 301130.SZ's current stock price?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) is currently trading at $29.22 per share. The stock has moved +0.55% today.
What is the analyst price target for 301130.SZ?
No analyst price targets are currently available for this stock.
What sector is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd in?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd operates in the Basic Materials sector, specifically within the Chemicals industry. The company is traded on the SHZ exchange.
What is 301130.SZ's market cap?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd has a market capitalization of $2.24 billion, making it a mid-cap company.
Does 301130.SZ pay dividends?
No, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd does not currently pay a dividend to shareholders.
Similar Stocks
Basic Materials Sector000637.SZ
Maoming Petro-Chemical Shihua Co., Ltd
$4.40
Mkt Cap: $2.3B
001378.SZ
Guangdong Decro Fi
$23.67
Mkt Cap: $2.4B
002136.SZ
Anhui Annada Titanium Industry Co., Ltd.
$13.37
Mkt Cap: $2.9B
002802.SZ
Wuxi Honghui New Materials Technology Co., Ltd.
$12.66
Mkt Cap: $2.3B
002809.SZ
Guangdong Redwall New Materials Co., Ltd.
$10.84
Mkt Cap: $2.3B
003017.SZ
Zhejiang Dayang Biology Technology Co.,Ltd.
$30.30
Mkt Cap: $2.5B
300169.SZ
Changzhou Tiansheng New Materials Co., Ltd.
$6.40
Mkt Cap: $2.1B
300610.SZ
Yangzhou Chenhua New Material Co., Ltd.
$12.01
Mkt Cap: $2.5B
300886.SZ
Anhui Hyea Aromas Co., Ltd.
$26.11
Mkt Cap: $2.0B
603041.SS
Jiangsu Maysta Chemical Co., Ltd.
$12.24
Mkt Cap: $2.2B
Explore stocks similar to 301130.SZ for comparison